A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Clinical trial NCT01235962 · COMPLETED

Trial details

NCT number: NCT01235962
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Cancer

Start date: 2010-11-30
Primary completion: 2015-10-15
Enrollment: 1538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.